Spectral Medical, Inc. (EDT.TO)
1.35
0.00 (0.00%)
CAD |
TSX |
Aug 25, 16:00
Spectral Medical Shareholders Equity (Quarterly) : -70.07M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -70.07M |
| March 31, 2026 | -70.77M |
| December 31, 2025 | -69.72M |
| September 30, 2025 | -68.66M |
| June 30, 2025 | -40.18M |
| March 31, 2025 | -38.74M |
| December 31, 2024 | -27.54M |
| September 30, 2024 | -31.28M |
| June 30, 2024 | -22.84M |
| March 31, 2024 | -20.14M |
| December 31, 2023 | -16.55M |
| September 30, 2023 | -10.15M |
| June 30, 2023 | -7.278M |
| March 31, 2023 | -4.326M |
| December 31, 2022 | -2.554M |
| September 30, 2022 | -3.602M |
| June 30, 2022 | -0.704M |
| March 31, 2022 | 2.151M |
| December 31, 2021 | 4.083M |
| September 30, 2021 | 6.493M |
| June 30, 2021 | -0.472M |
| March 31, 2021 | -0.228M |
| December 31, 2020 | -0.669M |
| September 30, 2020 | 1.352M |
| June 30, 2020 | 2.869M |
| Date | Value |
|---|---|
| March 31, 2020 | 0.279M |
| December 31, 2019 | 2.26M |
| September 30, 2019 | 3.585M |
| June 30, 2019 | 4.774M |
| March 31, 2019 | 5.401M |
| December 31, 2018 | 6.37M |
| September 30, 2018 | 5.953M |
| June 30, 2018 | 6.615M |
| March 31, 2018 | 2.824M |
| December 31, 2017 | 2.858M |
| September 30, 2017 | 3.439M |
| June 30, 2017 | 4.197M |
| March 31, 2017 | 5.17M |
| December 31, 2016 | 5.822M |
| September 30, 2016 | 6.794M |
| June 30, 2016 | 9.065M |
| March 31, 2016 | 12.47M |
| December 31, 2015 | 5.433M |
| September 30, 2015 | 7.684M |
| June 30, 2015 | 10.42M |
| March 31, 2015 | 6.648M |
| December 31, 2014 | 8.82M |
| September 30, 2014 | 11.23M |
| June 30, 2014 | 0.327M |
| March 31, 2014 | 2.726M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Resverlogix Corp. | -133.75M |
| Theratechnologies, Inc. | -38.39M |
| COSCIENS Biopharma, Inc. | 21.06M |
| Restart Life Sciences Corp. | 1.543M |
| Defence Therapeutics Inc | 5.415M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 3.19M |
| Total Liabilities (Quarterly) | 73.26M |
| Debt to Equity Ratio | -0.3529 |
| Current Ratio | 0.0403 |
| Net Debt Paydown Yield | -0.49% |